Everything you need to analyse a stock, in one place.
Stop rebuilding the same research from five different tabs. Get the figures, the charts and the context together, so you spend your time deciding — not collecting.
Loading…
No card required. Keep your free account when the trial ends.
Novo Nordisk
DKK 612.40 +1.8%
Timing Zone Buy signals: 64.4% positive trades in backtests 2019–2026. Past results are no guarantee. Unlock it with a free trial
Illustrative example — not real or current data.
Research shouldn't mean five tabs and a spreadsheet.
Hours spent jumping between annual reports, key figure sites, news and charts.
- Your holdings tracked by hand in a spreadsheet
- Ideas scattered across bookmarks and notes
- Hunting for quality stocks one by one
Analyse any stock in 30 seconds — everything on one page.
- Easy portfolio tracker
- 30 watchlists
- Scanning for quality stocks
Loading…
Everything a fundamental investor checks, already there.
Key figures, on the page
Profitability, growth and balance-sheet figures pulled onto one page — no tab-hopping.
Clear charts
Quality, value and timing shown visually, not buried in a spreadsheet.
Earnings calendar
See upcoming report dates before they surprise you.
Expert analyses
Daily analysis from our own team, not aggregated headlines.
Portfolio tools
Track your own holdings alongside our published model portfolios.
Sector analyses
See which sectors and industries actually have the wind behind them.
One page, not five browser tabs.
Novo Nordisk (NOVO)
DKK 612.40 +1.8%
Illustrative example — not real or current data.
Real people behind it, with real track records.
MyStockScanner is built and run by a small team who publish their own model portfolios and show up every week — not an anonymous algorithm.



A daily rhythm, not just a tool.
Start free. Upgrade only if you want to.
No card required for the trial, and no pressure to pay after it ends.
Loading current prices…
Questions before you start
Loading…